BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BI 3032950 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BI 3032950\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06636656-43@assetmemo.bio
DTSTAMP:20261121T004949Z
DTSTART;VALUE=DATE:20270730
DTEND;VALUE=DATE:20270731
SUMMARY:BI 3032950: Phase 2 readout est. (NCT06636656)
DESCRIPTION:BI 3032950\, phase 2\, Ulcerative Colitis.\nStudy: A Study to T
 est Whether BI 3032950 Helps People With Ulcerative Colitis\nEstimated pri
 mary completion: 30 July 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/bi-3032950#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT06636656
URL:https://assetmemo.bio/drug/bi-3032950#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
